BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27549363)

  • 1. The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD.
    Al-Shair K; Kolsum U; Singh D; Vestbo J
    Lung; 2016 Dec; 194(6):889-895. PubMed ID: 27549363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale.
    Al-shair K; Kolsum U; Berry P; Smith J; Caress A; Singh D; Vestbo J
    Thorax; 2009 Nov; 64(11):950-5. PubMed ID: 19720608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD.
    Al-shair K; Dockry R; Mallia-Milanes B; Kolsum U; Singh D; Vestbo J
    Respir Med; 2009 Oct; 103(10):1572-9. PubMed ID: 19560330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of dyspnoea and leg fatigue during exercise on health-related quality of life in patients with COPD.
    Katsura H; Yamada K; Wakabayashi R; Kida K
    Respirology; 2005 Sep; 10(4):485-90. PubMed ID: 16135172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.
    Al-shair K; Kolsum U; Dockry R; Morris J; Singh D; Vestbo J
    Respir Res; 2011 Jan; 12(1):3. PubMed ID: 21208443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).
    Al-Shair K; Muldoon EG; Morris J; Atherton GT; Kosmidis C; Denning DW
    Respir Med; 2016 May; 114():117-22. PubMed ID: 27109821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD.
    Tödt K; Skargren E; Kentson M; Theander K; Jakobsson P; Unosson M
    Int J Chron Obstruct Pulmon Dis; 2014; 9():17-25. PubMed ID: 24368883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
    Bestall JC; Paul EA; Garrod R; Garnham R; Jones PW; Wedzicha JA
    Thorax; 1999 Jul; 54(7):581-6. PubMed ID: 10377201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the Brazilian Portuguese version of the fatigue severity scale and its correlation with pulmonary function, dyspnea, and functional capacity in patients with COPD.
    Valderramas S; Camelier AA; Silva SA; Mallmann R; de Paulo HK; Rosa FW
    J Bras Pneumol; 2013; 39(4):427-33. PubMed ID: 24068263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exertional Dyspnoea responses reported in the Dyspnoea Challenge and measures of disease severity in COPD.
    Aitken CR; Walsh JR; Stewart GM; Sabapathy S; Adams L; Morris NR
    Respir Physiol Neurobiol; 2022 Oct; 304():103941. PubMed ID: 35777721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyspnea in COPD: beyond the modified Medical Research Council scale.
    Camargo LA; Pereira CA
    J Bras Pneumol; 2010; 36(5):571-8. PubMed ID: 21085822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.
    Luo Y; Zhou L; Li Y; Guo S; Li X; Zheng J; Zhu Z; Chen Y; Huang Y; Chen R; Chen X
    Respir Care; 2016 May; 61(5):680-8. PubMed ID: 26814217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and rapid test of physical performance inchronic obstructive pulmonary disease.
    Albarrati AM; Gale NS; Enright S; Munnery MM; Cockcroft JR; Shale DJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1785-91. PubMed ID: 27536090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?
    Boer LM; Asijee GM; van Schayck OC; Schermer TR
    Prim Care Respir J; 2012 Jun; 21(2):202-7. PubMed ID: 22453664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the BODE index correlate with quality of life in patients with COPD?
    Araujo ZT; Holanda G
    J Bras Pneumol; 2010; 36(4):447-52. PubMed ID: 20835591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physical training on fat-free mass in patients with chronic obstructive pulmonary disease (COPD).
    Emtner M; Hallin R; Arnardottir RH; Janson C
    Ups J Med Sci; 2015 Mar; 120(1):52-8. PubMed ID: 25430624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillometry as a Predictor of Exercise Tolerance in COPD.
    Yamamoto A; Shirai T; Hirai K; Tanaka Y; Watanabe H; Endo Y; Shimoda Y; Suzuki T; Noguchi R; Mochizuki E; Sakurai S; Saigusa M; Akamatsu T; Shishido Y; Akita T; Morita S; Asada K
    COPD; 2020 Dec; 17(6):647-654. PubMed ID: 33183076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.